Suppr超能文献

用于早期卵巢癌检测的基于血清的生物标志物的开发所面临的挑战。

Challenges related to developing serum-based biomarkers for early ovarian cancer detection.

机构信息

Clinical Genetics Branch,Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA.

出版信息

Cancer Prev Res (Phila). 2011 Mar;4(3):303-6. doi: 10.1158/1940-6207.CAPR-11-0053.

Abstract

In this issue of the journal, Cramer and colleagues and Zhu and colleagues report carefully designed phase 3 assessments of candidate ovarian cancer screening biomarkers. The main conclusion is that CA-125 remains the "best of a bad lot"; the new candidates have fallen short of expectations. We review factors impeding the development of an effective ovarian cancer screening strategy, highlight the requirements related to validating proposed screening biomarkers, and emphasize the risks from premature clinical applications of unvalidated tests, all underscoring the need for new research strategies.

摘要

在本期杂志中,Cramer 及其同事以及 Zhu 及其同事报告了精心设计的候选卵巢癌筛查生物标志物的 3 期评估。主要结论是 CA-125 仍然是“差中之差”;新的候选者未能达到预期。我们回顾了阻碍有效卵巢癌筛查策略发展的因素,强调了与验证拟议筛查生物标志物相关的要求,并强调了未经验证的测试过早临床应用的风险,所有这些都强调了需要新的研究策略。

相似文献

1
Challenges related to developing serum-based biomarkers for early ovarian cancer detection.
Cancer Prev Res (Phila). 2011 Mar;4(3):303-6. doi: 10.1158/1940-6207.CAPR-11-0053.
2
3
Personalizing CA125 levels for ovarian cancer screening.
Cancer Prev Res (Phila). 2011 Sep;4(9):1356-9. doi: 10.1158/1940-6207.CAPR-11-0378.
4
Protein biomarkers of ovarian cancer: the forest and the trees.
Future Oncol. 2012 Jan;8(1):55-71. doi: 10.2217/fon.11.135.
6
Ovarian Cancer Biomarkers: Moving Forward in Early Detection.
Adv Exp Med Biol. 2020;1219:355-363. doi: 10.1007/978-3-030-34025-4_18.
7
Prognostic biomarkers in ovarian cancer.
Cancer Biomark. 2010;8(4-5):231-51. doi: 10.3233/CBM-2011-0212.
8
Early Detection of Ovarian Cancer.
Hematol Oncol Clin North Am. 2018 Dec;32(6):903-914. doi: 10.1016/j.hoc.2018.07.003. Epub 2018 Sep 28.
9
The quest for ovarian cancer screening biomarkers: are we on the right road?
Int J Gynecol Cancer. 2012 May;22 Suppl 1:S35-40. doi: 10.1097/IGC.0b013e318251ccaa.

引用本文的文献

2
Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning.
Commun Med (Lond). 2023 Jan 20;3(1):10. doi: 10.1038/s43856-023-00237-5.
7
Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model.
J Proteome Res. 2019 Aug 2;18(8):3184-3194. doi: 10.1021/acs.jproteome.9b00263. Epub 2019 Jul 10.
8
Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
PLoS One. 2018 Dec 28;13(12):e0209515. doi: 10.1371/journal.pone.0209515. eCollection 2018.
9
Current Standards and Recent Advances in Biomarkers of Major Endocrine Tumors.
Front Pharmacol. 2018 Sep 10;9:963. doi: 10.3389/fphar.2018.00963. eCollection 2018.
10
Another Round of "Clue" to Uncover the Mystery of Complex Traits.
Genes (Basel). 2018 Jan 25;9(2):61. doi: 10.3390/genes9020061.

本文引用的文献

1
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
Cancer Prev Res (Phila). 2011 Mar;4(3):375-83. doi: 10.1158/1940-6207.CAPR-10-0193.
2
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Cancer Prev Res (Phila). 2011 Mar;4(3):365-74. doi: 10.1158/1940-6207.CAPR-10-0195.
3
Status of tumor markers in epithelial ovarian cancer has there been any progress? A review.
Gynecol Oncol. 2011 Jan;120(1):152-7. doi: 10.1016/j.ygyno.2010.09.002. Epub 2010 Oct 14.
4
Cancer biomarkers: can we turn recent failures into success?
J Natl Cancer Inst. 2010 Oct 6;102(19):1462-7. doi: 10.1093/jnci/djq306. Epub 2010 Aug 12.
5
Conflicting views on the molecular structure of the cancer antigen CA125/MUC16.
Dis Markers. 2010;28(6):385-94. doi: 10.3233/DMA-2010-0719.
6
Cancer statistics, 2010.
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
7
Biomarkers for ovarian cancer detection and therapy.
Cancer Biol Ther. 2010 May 1;9(9):668-77. doi: 10.4161/cbt.9.9.11610. Epub 2010 May 24.
8
Ovarian cancer: the duplicity of CA125 measurement.
Nat Rev Clin Oncol. 2010 Jun;7(6):335-9. doi: 10.1038/nrclinonc.2010.44. Epub 2010 Apr 6.
9
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
10
Clinical practice. Screening for ovarian cancer.
N Engl J Med. 2009 Jul 9;361(2):170-7. doi: 10.1056/NEJMcp0901926.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验